HART News and Press, IQ Healthy Hearts ETF From 11/22/23

2023-11-22 02:15:00 ET Summary Q3 earnings season had many familiar refrains relative to the year’s first two quarters. One difference was a return to positive earnings growth for the first time since Q3 2022. Not unlike the first two quarters of the year, earnings for ...

2023-11-21 09:05:00 ET Summary A more volatile macroeconomic regime, alongside relatively high rates, may mean investors need to demand greater compensation for taking on equity risk; they can meet this higher performance bar by getting precise about targeted opportunities. The AI...

2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...

2023-11-14 05:40:00 ET Summary Healthcare stocks have underperformed the global market this year. Investors in healthcare stocks have been disappointed in 2023. Active investors can find attractively valued companies that benefit from durable business growth trends across the ...

2023-11-03 03:30:00 ET Summary Following a strong first half of 2023, third quarter returns were more challenged across almost all asset classes. One outlier was high-yield debt, which often serves as a way to de-risk equity exposures when stocks are under pressure. Most year-...

2023-10-23 12:05:00 ET Summary U.S. corporate earnings have stagnated with the economy. We stay selective in stocks and harness mega forces like artificial intelligence as key profit centers. The 10-year U.S. Treasury yield hit 16-year highs near 5.0% last week, while U.S. stocks ...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...

2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...

2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...